1. Home
  2. EVOK vs RCG Comparison

EVOK vs RCG Comparison

Compare EVOK & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evoke Pharma Inc.

EVOK

Evoke Pharma Inc.

HOLD

Current Price

$11.00

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

RCG

RENN Fund Inc

N/A

Current Price

$2.63

Market Cap

18.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
EVOK
RCG
Founded
2007
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
18.0M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
EVOK
RCG
Price
$11.00
$2.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.4K
5.9K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
0.98%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,424,652.00
N/A
Revenue This Year
$58.96
N/A
Revenue Next Year
$57.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
67.40
N/A
52 Week Low
$1.94
$1.52
52 Week High
$10.99
$1.90

Technical Indicators

Market Signals
Indicator
EVOK
RCG
Relative Strength Index (RSI) 85.18 53.38
Support Level $10.66 $2.54
Resistance Level $10.99 $2.65
Average True Range (ATR) 0.04 0.08
MACD -0.18 0.01
Stochastic Oscillator 95.00 89.37

Price Performance

Historical Comparison
EVOK
RCG

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

Share on Social Networks: